Not logged in : Login

About: Amarin Corporation     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent, within Data Space : ods-qa.openlinksw.com:8896 associated with source document(s)

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid. In July 2012, their lead-candidate drug named Vascepa (AMR-101) received FDA-approval, competing against GlaxoSmithKline's Lovaza.

AttributesValues
type
sameAs
wasDerivedFrom
dbpedia-owl:abstract
  • Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid. In July 2012, their lead-candidate drug named Vascepa (AMR-101) received FDA-approval, competing against GlaxoSmithKline's Lovaza.
  • Amarin Corporation ist ein irisch-amerikanischer Pharmakonzern mit Sitz in Dublin und Bridgewater. Das im Jahr 1993 gegründete Unternehmen ist auf die Herstellung und Vermarktung von Medikamenten zur Behandlung von Herz-Kreislauf-Erkrankungen spezialisiert und brachte mit Vascepa (US) 2013 ein entsprechendes Präparat auf den nordamerikanischen Markt.
dbpedia-owl:thumbnail
dbpedia-owl:type
dbpedia-owl:wikiPageExternalLink
dbpedia-owl:wikiPageID
dbpedia-owl:wikiPageRevisionID
comment
  • Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid. In July 2012, their lead-candidate drug named Vascepa (AMR-101) received FDA-approval, competing against GlaxoSmithKline's Lovaza.
  • Amarin Corporation ist ein irisch-amerikanischer Pharmakonzern mit Sitz in Dublin und Bridgewater. Das im Jahr 1993 gegründete Unternehmen ist auf die Herstellung und Vermarktung von Medikamenten zur Behandlung von Herz-Kreislauf-Erkrankungen spezialisiert und brachte mit Vascepa (US) 2013 ein entsprechendes Präparat auf den nordamerikanischen Markt.
label
  • Amarin
  • Amarin Corporation
dbpprop:wikiPageUsesTemplate
name
  • Amarin Corporation
dbpprop:numEmployees
  • ~1000
described by
topic
name
  • Amarin Corporation
depiction
  • External Image
homepage
dbpprop:products
  • Vascepa
http://purl.org/li...ics/gold/hypernym
location
dbpprop:location
dbpprop:type
Subject
is primary topic of
has close match
dbpedia-owl:foundingYear
dbpprop:logo
  • Amarin logo.jpg
dbpprop:revenue
  • 6.141E8
dbpedia-owl:wikiPageLength
dbpedia-owl:wikiPageWikiLink
Faceted Search & Find service v1.17_git55 as of Mar 01 2021


Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3322 as of Mar 14 2022, on Linux (x86_64-generic-linux-glibc25), Single-Server Edition (7 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software